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Abstract
Hypoxia is an important environmental change in many cancers. Hypoxic niches can be occupied by cancer stem/
progenitor-like cells that are associated with tumor progression and resistance to radiotherapy and chemotherapy.
However, it has not yet been fully elucidated how hypoxia influences the stem-like properties of prostate cancer cells. In this
report, we investigated the effects of hypoxia on human prostate cancer cell lines, PC-3 and DU145. In comparison to
normoxia (20% O2), 7% O2 induced higher expressions of HIF-1a and HIF-2a, which were associated with upregulation of
Oct3/4 and Nanog; 1% O2 induced even greater levels of these factors. The upregulated NANOG mRNA expression in
hypoxia was confirmed to be predominantly retrogene NANOGP8. Similar growth rates were observed for cells cultivated
under hypoxic and normoxic conditions for 48 hours; however, the colony formation assay revealed that 48 hours of
hypoxic pretreatment resulted in the formation of more colonies. Treatment with 1% O2 also extended the G0/G1 stage,
resulting in more side population cells, and induced CD44 and ABCG2 expressions. Hypoxia also increased the number of
cells positive for ABCG2 expression, which were predominantly found to be CD44
bright cells. Correspondingly, the sorted
CD44
bright cells expressed higher levels of ABCG2, Oct3/4, and Nanog than CD44
dim cells, and hypoxic pretreatment
significantly increased the expressions of these factors. CD44
bright cells under normoxia formed significantly more colonies
and spheres compared with the CD44
dim cells, and hypoxic pretreatment even increased this effect. Our data indicate that
prostate cancer cells under hypoxia possess greater stem-like properties.
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Introduction
Somatic tumors, including prostate cancer, contain a small
subset of stem-like cells, called cancer stem cells, with capacities for
self-renewal, differentiation, and initiation of new tumors. It has
been demonstrated that cancer stem cells can escape from
radiotherapy and chemotherapy, and are able to form metastatic
tumors in other organs [1,2]. Cancer stem cells preferentially
reside in specific hypoxic microenvironment-niches, often existing
inside tumors [3,4].
The hypoxia inducible factors (HIFs) are key regulators found in
mammalian cells under lower oxygen tension; they are involved
with multiple functions, such as cell survival, angiogenesis, and
stem cell maintenance, and play essential roles in cellular and
systemic homeostasis in response to hypoxia [5]. HIFs are
heterodimers; HIF1A (HIF-1a) and EPAS1 (HIF-2a) are the two
major isoforms of the a-subunit, and share a high degree of
sequence homology. Oct3/4 (also called POU5F1) and Nanog are
embryonic stem cell markers that are important for transcription
and in maintaining self-renewal of embryonic stem cells and
primordial germ cells. They have also been identified in different
somatic tumors, including head and neck, lung, colorectal,
ovarian, and prostate cancers [6–11]. Comparatively, the
expressions of these genes are down-regulated in all differentiated
somatic cell types, in vitro as well as in vivo [12,13]. NANOG, also
called NANOG1, has several pseudogenes, and among them
NANOGP8 has later been confirmed to be a retrogene. Both
NANOG1 and NANOGP8 expressions have been identified in
different cancer cell types [14,15], including prostate cancer cells
[16].
A number of surface markers have been used to isolate putative
cancer stem/progenitor cells. In prostate cancer, the early
progenitor cells are associated with several specific surface
markers, such as CD44, CD133, and CXCR4 [17–19]. Side
population technology has also been used to isolate cancer stem
cells with the ability to pump out Hoechst 33342 [20]. Efflux of the
dye is attributed to members of the ATP-binding cassette family,
such as ABCG2 (breast cancer resistance protein, BCRP). The
upregulation of ABCG2 is also responsible for chemotherapeutic
resistance in certain cancer cells [21]. In breast and prostate
cancers, previous studies have identified CD44
+ or CD117
+/
ABCG2
+ cells with stem-like characteristics, such as increased
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genes, and stronger ability to form tumors in animal models
[19,22,23].
Hypoxia helps embryonic stem cells to maintain stemness and
higher oxygen tensions drive cells into proliferation and differen-
tiation, which are more susceptible to conventional treatment
modalities [24,25]. Similar results have been observed in adult
cells, like adipocytes, fibroblasts, and several types of cancer cells
[26–28]. However, the effects of hypoxia on prostate cancer cells
have not been fully elucidated. Therefore, in this study we
examined the prostate cancer cell lines PC-3 and DU145 at
different oxygen tensions in order to better understand the effect of
hypoxia on the stem-like properties of the cells. Stemness factors,
Oct3/4 and Nanog, were expressed at higher levels in the cells
under hypoxic cultivation and these cells exhibited elevated colony
formation potential compared to the cells under normoxic
condition. Furthermore, the upregulated NANOG mRNA expres-
sion under hypoxia was confirmed mainly derived from the
retrogene NANOGP8. In these prostate cancer cell lines, hypoxia
also increased the fraction of side population cells, extended the
G0/G1 stage and resulted in higher levels ABCG2 and CD44
expressions. Additional experiments demonstrated that CD44
bright
cells exhibited significantly greater stemness, as verified by colony
formation assay, sphere growth assay, and stemness factor
expression analyses.
Materials and Methods
Cell culture
Human prostate cancer cell lines, PC-3 and DU145, were
purchased from ATCC (American Type Culture Collection, USA)
and maintained in our lab for this study. For conventional cell
culture, cells were seeded in culture flasks with RPMI 1640
medium supplemented with 10% fetal bovine serum, 100 units/ml
penicillin, and 100 mg/ml streptomycin. Cultures were maintained
at 37uC in a humidified incubator in an atmosphere of 20% O2,
5% CO2, and 75% N2.
The Xvivo Closed Incubation System (Xvivo system 300 C,
BioSpherix, New York, USA) was used in this study in order to
accurately maintain different oxygen tensions in different cham-
bers. After 24 hours of cultivation in conventional cell culture
(allowing cells to attach onto the flasks), the cells were transferred
into different chambers with 1% O2,5 %C O 2, and 94% N2;7 %
O2,5 %C O 2, and 88% N2; or 20% O2,5 %C O 2 and 75% N2 for
variable periods of time before being harvested for additional
analysis.
Semiquantitative reverse transcription-PCR (RT-PCR)
Total RNA was extracted from the cultivated cells using the
RNeasy Kit (Qiagen, CA, USA) according to the manufacturer’s
instruction. To eliminate any DNA, DNase I was used in the RNA
isolation procedure. RNA sample concentrations were quantified
using a spectrophotometer (Nanodrop ND-1000, USA) at OD260/
280.
Complementary DNA (cDNA) was subsequently synthesized
from 5 mg total RNA using the Multiscribe reverse transcriptase
(Applied Biosystems, Foster City, CA). The conditions for reverse
transcription were: 25uC for 10 minutes, 37uC for 12 minutes,
85uC for 5 minutes, followed by holding at 4uC. cDNA was stored
at 270uC for later PCR analyses.
PCR amplification of cDNA was performed using a PCR
system (DOPPIO VWR, UK) and the following program: initial
denaturation at 95uC for 10 minutes; followed by 30 cycles (28
cycles for GAPDH) of annealing at 60uC for 30 seconds, and
extension at 72uC for 30 seconds; followed by termination with a
10 minute elongation step at 72uC. The primers used for RT-PCR
were: for Nanog, F 59-ATGCCTCACACGGAGACTGT-39 and
R5 9-AGGGCTGTCCTGAATAAGCA-39, amplifying a 66-bp
fragment; for Oct3/4, F 59-ACATGTGTAAGCTGCGGCC-39
and R 59-GTTGTGCATAGTCGCTGCTTG-39, amplifying a
297-bp fragment; for HIF-1a,F5 9-AGTGTACCCTAAC-
TAGCCGAGGAA-39 and R 59-CTGAGGTTGGTTACTG-
TTGGTATCA-39, amplifying a 113-bp fragment; for HIF-2a,F
59-GACCAGCAGATGGACAACTTGTAC-39 and R 59-CA-
GAAAGATCATGTCGCCATCTT-39, amplifying a 84-bp frag-
ment; and for GAPDH, F 59-CCTCAAGATCATCAGCA-
ATGC-39 and R 59-TGGTCATGAGTCCTTCCACG-39, am-
plifying a 101-bp product. The experiments were repeated at least
three times.
The amplified PCR products were separated by 7.5%
polyacrylamide gel electrophoresis, stained with GelRed (Molec-
ular Probes, Invitrogen), and visualized with a syngene image
system (G: BOX Syngene, USA).
The mRNA expressions of NANOG1 and NANOGP8 were
measured by quantitative PCR using a Taqman ABI 7900
Sequence Detector System (Applied Biosystems). The published
specific primers and probes [29] were used in this study . For
NANOG1: forward primer was 59-CGCCCTGCCTAGAAAAGA-
CATTT -39, reverse primer was 59-AGAAGCCGTCTCTGGC-
TATAGATAA -39, and the probe was CTGCTAAGGAC-
AACATTGAT; for NANOGP8: forward primer was 59-
CGCCCTGCCTAGAAAAGACATTT-39 , reverse primer was
59-ACGAGTTTGGATATCTTTAGGGTTTAGAATC-39, and
the probe was CCTTGGCTGCCGTCTCTG. All the primers
and probes labeled with FAM-MGB were obtained from Applied
Biosystems. The GAPDH was used as an internal control and the
Ct values at 20% O2 were used as calibrators for evaluating
NANOG1 and NANOGP8 expression levels in response to hypoxia.
The experiments were performed in duplicate. The expression
levels of the NANOG1 and NANOGP8 were analyzed through the
DDCt method [29].
Immunoblotting
Cells were quickly rinsed with ice-cold phosphate-buffered
saline (PBS) and scraped into RIPA buffer (25 mM Tris HCl
pH 7.6, 100 mM NaCl, 1% NP40, 1% sodium deoxycholate,
0.1% SDS; Thermo Scientific Pierce, Germany), with protease
inhibitors (0.1 mM aprotinin, 1.0 mM PMSF, 1 mM leupeptin,
1 mM pepstatin) added immediately before use. The samples were
centrifuged at 15,000 rpm for 15 minutes at 4uC and the
supernatants were transferred to new tubes. The protein
concentrations were measured with a Bio-Rad protein assay
according to the manufacturer’s instruction. The samples were
heated with a benchtop heater (Model 111002, Boekel Scientific,
USA) at 100uC for 5 minutes in SDS-loading buffer (500 mM
Tris-HCl pH 6.8; 10% Glycerol, 2% SDS, 0.6 M DTT, 0.05%
bromophenol blue), and then an equal amount of protein (50 mg)
per sample was subjected to 10% SDS-PAGE and transferred to
polyvinylidene difluoride transfer membrane (BIO-RAD, USA).
Membranes were blocked with 5% non-fat dry milk in TBS-
Tween for 60 minutes at room temperature and then incubated
with the primary antibodies at optimal dilution in TBST/5% milk
overnight at 4uC. The optimized antibodies used in this study
included: HIF-1a (1 mg/ml MAB1536, R&D), HIF-2a (1 mg/ml
MAB2886, R&D), GAPDH (0.2 mg/ml AF5718, R&D), Oct3/4
(1 mg/ml MAB1759, R&D), Nanog (1 mg/ml AF1997, R&D), and
ABCG2 (0.5 mg/ml B7059, Sigma-Aldrich). The membranes were
then incubated with secondary HRP-conjugated antibodies and
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cence (GE Healthcare, UK). Western blotting experiments were
repeated at least three times.
Cell block preparation
Cells were grown to 80% confluence and then were digested
with 0.25% trypsin and EDTA (Invitrogen, USA), harvested, and
centrifuged at 2000 rpm for 10 minutes. Supernatants were
discarded, 3 drops of plasma and 2 drops of thrombin were
added to the sedimentation, and the contents were carefully mixed
by tube rotation. One minute later, the mixture was coagulated
and 4% buffered formalin was added to the tube for fixation. The
coagulated mass was then placed in linen paper and used to
construct a paraffin block by the conventional process.
Immunocytochemistry
Cell blocks were sliced into 4-mm paraffin sections that were
then deparaffinized using PT-Link apparatus. Next, the sections
were rinsed with DAKO wash buffer, incubated with hydrogen
peroxide for 5 minutes, and then incubated with primary antibody
for 30 minutes at room temperature. The antibodies used and
their concentrations were: HIF-1a (mouse, 1:200; catalog number:
NB100-150, Novus), HIF-2a (rabbit, 1:100; catalog number:
NB100-122, Novus), Oct3/4, (goat, 10 mg/ml; catalog number:
AF1759, R&D) and Nanog (goat, 5 mg/ml; catalog number:
AF1997, R&D).
After another rinse with DAKO wash buffer, mouse/rabbit
EnVision FLEX+Linker reagent was added and samples were
incubated for 15 minutes at room temperature, followed by
incubation with EnVision FLEX+HRP for 30 minutes at room
temperature. Samples with primary antibodies from goat were
incubated for 30 minutes at room temperature with mouse anti-
goat IgG before the addition of mouse EnVision FLEX+Linker
reagent and EnVision FLEX+HRP as described above. The
sections were rinsed, color reaction developed with DAB reagent,
counterstained in hematoxylin for 20 seconds, dehydrated, and
mounted under glass cover slips in preparation for evaluation by
microscopy.
Cell counting (cell proliferation rate)
Cell proliferation was evaluated by counting cell numbers using
the Electronics Countess Automated Cell Counter (Invitrogen,
USA). After trypsinization, the floating cells were collected to
create a cell suspension that contained no obvious cell clusters. In
each preparation, 10 ml of cell suspension was mixed with 0.4%
trypan blue dye (1:1) before being loaded onto a cell counting
chamber slide for cell counting. The number of viable cells that
were able to exclude the dye was counted for each experimental
condition. For each sample, the cell number was counted at least
three times.
Colony formation assay
Using six-well plates, 500 cells per well were maintained in
oxygen tensions of 1%, 7%, and 20% for 48 hours. All plates were
then placed in an incubator with 20% O2 for 2 weeks for
observation of colony formation. Colonies were fixed with 4%
buffered formalin for 15 minutes, and then stained with 1% crystal
violet for 30 minutes. The plates were gently washed with PBS
and dried before microscopic colony evaluation. Colonies that
contained more than 30 cells were counted. Colony formation
efficiency was calculated as follows: colony formation efficiency=
colonies/input cells6100%. Data are representative of three
independent experiments.
Cell cycle analysis
After incubation under different oxygen tensions, including 1%
or 20% O2, the PC-3 and DU145 cells were harvested and fixed
with methanol at 220uC overnight. These cells were used to
prepare a single cell suspension to which was added 1.5 mg/ml of
Hoechst 33258 before the cells were kept on ice for 30 minutes.
After that, the samples were analyzed with an LSRII flow
cytometer (Becton Dickinson, San Jose, CA, USA).
Side population assay
Cells grown to 80% confluence (about 1610
6 cells) were
harvested and suspended in prewarmed RPMI 1640 medium
containing 2% fetal bovine serum and 2 mM HEPES buffer.
Hoechst 33342 dye (stock solution of 1 mg/ml; Sigma) was then
added to a final concentration of 5 mg/ml, and the mixture was
incubated with intermittent shaking for 90 minutes at 37uC, in the
presence or absence of verapamil (50 mM; Sigma). Then, the cells
were washed with ice-cold HBSS with 2% FBS, centrifuged at
4uC, and resuspended in ice-cold HBSS containing 2% FBS.
Propidium iodide was added to the suspended cells to a final
concentration of 2 mg/ml, in order to reveal viable cells. Before
analysis, the cells were filtered through a 70-mm cell strainer to
obtain a single cell suspension. The cell aggregates were discarded
from the analysis by doublet discrimination and single cells were
analyzed on a LSRII flow cytometer (BD Biosciences). Hoechst
33342 dye was excited at 350 nm and the side-population cells
were visualized by the use of red (red, 660/10 nm) vs. blue (blue,
424/44 nm) detection.
ABCG2/CD44 phenotype and Fluorescence-activated cell
sorting (FACS)
After 48 hours of incubation at oxygen tensions of 1% and
20%, the PC-3 and DU145 cells were trypsinized, counted,
washed with cold FACS buffer (PBS+BSA 0.03%), and
resuspended to a final concentration of 10
6 cells/ml. The cells
were pre-blocked with 5% BSA for 30 minutes on ice before they
were stained with primary antibodies (anti-CD44 monoclonal
antibody directly conjugated with APC (allophycoyanin) and
anti-ABCG2 monoclonal antibody directly conjugated with FE
(phycoerythin); BD Pharmingen Company) on ice, in the dark,
for 30 minutes. Cell suspensions were washed twice, resuspended
in 400 ml FACS buffer, and filtered through a 70-mmn y l o n
mesh. Samples were analyzed on a flow cytometer (Becton
Dickinson, San Jose, CA, USA) for detection of ABCG2 and
CD44, and a FACS DiVa cell sorter was used for cell sorting.
After cultivation at 1% or 20% O2 for 48 hours, the PC-3 and
DU145 cells were sorted based on CD44 expression. For the
CD44 positive cells, only the top 10% expressing cells were
selected (called CD44
bright); for the CD44 negative cells, the
bottom 10% expressing cells were isolated (called CD44
dim). For
each sample, viable and single cells were gated; APC Mouse
IgG2b (BD Pharmingen, USA) and FE Mouse IgG2b (BD
Pharmingen, USA) isotype controls were used as negative
controls.
Sphere formation assay
The assay used was based on previously described methods
[30]. After the CD44
bright cells were sorted with the method as
described above, single CD44
bright and CD44
dim cells were plated
at a density of 300 cells per well, in ultralow attachment six-well
plates (Ultra low cluster plates, Life sciences). These cells were
cultivated in serum free DMEM/F12 medium (Invitrogen)
supplemented with 20 ng/ml EGF and 20 ng/ml bFGF for ten
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under inverse miscopy and counted (more than 30 cells within a
sphere was considered to be a full sphere). Data are representative
of three independent experiments.
Statistical analyses
For each experiment, data are shown as mean 6 SEM of at
least three independent experiments; SPSS software (version 16.0)
was used for data analysis. Statistical analyses were performed
Figure 1. Hypoxia increases the expressions of HIF-1a and HIF-2a. (A) In comparison to the cells cultivated at 20% O2, the cells cultivated at
7% O2 show higher levels of HIF-1a and HIF-2a, and the cells cultivated at 1% O2 show the highest levels of HIF-1a and HIF-2a by both RT-PCR and
immunoblotting. (B) Immunocytochemistry reveals higher levels of HIF-1a and HIF-2a expressions in the cells cultivated under 7% O2 and the highest
levels of HIF-1a and HIF-2a expressions in the cells cultivated under 1% O2 for both cell lines. The breast carcinoma sections were used as positive
controls for both HIF-1a and HIF-2a. All photos were originally taken at 2006and all the insets were taken at 4006.
doi:10.1371/journal.pone.0029170.g001
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e29170Figure 2. Hypoxia increases the expressions of Oct3/4 and Nanog. (A) In comparison to the cells cultivated at 20% O2, the cells cultivated at
7% O2 show higher levels of Oct3/4 and Nanog expressions, and the cells cultivated at 1% O2 show the highest levels of Oct3/4 and Nanog
expressions in PC-3 and DU145 cell lines by both RT-PCR and immunoblotting. (B) Immunocytochemistry reveals corresponding higher levels of Oct3/
4 and Nanog expressions at 7% O2 and the highest levels of Oct3/4 and Nanog expressions at 1% O2, in comparison to the cells cultivated at 20% O2
for both cell lines. Human seminoma tissue sections were used as positive controls for these two antibodies. All photos were originally taken at 2006
and all the insets were taken at 4006.
doi:10.1371/journal.pone.0029170.g002
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considered statistical significance).
Results
Hypoxia induces expression of HIF-1a, HIF-2a, Oct3/4 and
Nanog
HIF-1a and HIF-2a, the major transcriptional factors respond-
ing to hypoxia, were examined in human prostate cancer cells PC-
3 and DU145 that were exposed to different oxygen tensions for
variable periods of time. At 20% O2 tension, HIF-1a and HIF-2a
were weakly expressed at both the mRNA and protein levels;
comparatively higher levels of HIF-1a and HIF-2a expression
were observed at 7% O2 tension, and the highest levels were seen
at 1% O2 tension (Figure 1A). At reduced oxygen tension levels,
these two factors were already upregulated after 6 hours of
cultivation. Their expressions reached the highest levels at
12 hours of cultivation at 7% O2 tension, but reached highest
levels at only 6 hours of cultivation at 1% O2. Protein expression
after 48 hours of cultivation at different oxygen tensions was also
studied by immunocytochemistry (Figure 1B). The expressions of
HIF-1a and HIF-2a were consistently higher in the hypoxia-
treated cells, in agreement with the findings obtained by RT-PCR
and immunoblotting.
Oct3/4 and Nanog are frequently used as markers for the
undifferentiated cells and play an essential role in sustaining
capacity of self-renewal in adult stem cells [31,32]. The
expressions of these transcription factors were also examined in
PC-3 and DU145 cells that were cultivated at different oxygen
tensions. At both the mRNA and protein levels (Figure 2A), weak
expressions of Oct3/4 and Nanog were revealed in these two cell
lines cultivated at 20% O2 tension, while their expressions were
upregulated in cells cultivated under 7% and 1% O2 conditions. In
both cell lines, the expressions of these two factors were higher at
1% O2 than at 7% O2. As was also seen in immunoblotting
analyses (Figure 2A), Oct3/4 and Nanog began to substantially
increase as early as 6 hours after the cells were transferred to 1%
O2, and reached maximum levels at 12 hours for both cell lines.
When the cells were placed in 7% O2, the expressions of these two
factors were also substantially elevated after 6 hours, and reached
the highest levels at 12 hours cultivation; however, these expres-
sion levels were weaker than those observed in cells exposed to 1%
O2. Similar results were also obtained by immunocytochemistry
(Figure 2B). Following exposure to hypoxic condition, enhanced
Oct3/4 and Nanog expressions were seen in both PC-3 and
DU145 cells.
To determine whether the elevated NANOG expression was
derived from NANOG1 or NANOGP8, quantitative RT-PCR
analyses were further performed, with the corresponding cells
cultivated under normoxia as calibrators. It was repeatedly verified
that the NANOG1 expression in the cells under normoxia was at
very low level, with average Ct values 37.24 and 37.37 for the PC-
3 cell and DU145 cells, respectively. However, the NANOGP8
expression in the cells under normoxia was relatively high, with
average Ct values 33.56 and 33.51 for the PC-3 cell and DU145
cells, respectively. Although higher levels NANOG1 and NANOGP8
expressions could be observed in both cell lines under hypoxia, the
elevated NANOG expression was confirmed predominantly NA-
NOGP8, with up to 6-fold and 10-fold increase in expression in the
PC-3 and DU145 cells under 1% O2, respectively (Figure 3). Since
the NANOG1 expression in the cells under normoxia was extremely
low, the 2.6-fold and 3.1-fold increase in expression of this gene in
the PC-3 and DU145 cells under 1% O2 represented still quite low
expression level.
Hypoxia increases colony formation capability and
extends G0/G1 stage
Since hypoxia increased the expression of stemness factors, we
next investigated whether hypoxia influenced the proliferation of
these cells. The PC-3 and DU145 cells were cultivated under
normoxia (20% O2) or hypoxia conditions (1% O2 and 7% O2)
for 48 hours for the proliferation assay. As shown in Figure 4A,
for each cell line there were no statistically significant differences
in proliferation of the cells cultivated at different oxygen tensions
(P.0.05), although the cells grew somewhat slower under
Figure 3. Quantitative PCR results of NANOG1 and NONOGP8.
Compared to the cells under normoxia, there are elevated NANOG1 and
NONOGP8 expressions in the cells under 7% O2 for both cell lines, with
up to 1.8-fold increase NANOG1 expression and up to 2.5-fold NONOGP8
increase in both cell lines; the cells under 1% O2 express even higher
levels of NANOG1 and NONOGP8, with 2.6-fold and 3.1-fold increase in
NANOG1 expression in the PC-3 and DU145 cell lines, respectively, and
with 6-fold and 10-fold increase in NONOGP8 expressions in the PC-3
and DU145 cell lines, respectively.
doi:10.1371/journal.pone.0029170.g003
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pretreatment could influence clonogenicty in these cells. The
cells were initially exposed to different oxygen tensions for
48 hours, followed by transfer to a normoxic chamber (20% O2)
for 14 days for the colony formation assay. Compared to the cells
that were steadily cultivated at 20% O2, more colonies were
observed in the cells that were pretreated at 7% O2, and even
more colonies were seen in the cells pretreated at 1% O2
(Figure 4B). Compared to the cells always cultivated under
normoxia, statistically significantly higher colony formation
efficiency was identified in the hypoxia-pretreated PC-3 and
DU145 ells (Figure 4C). Cell cycle analyses demonstrated an
extended G0/G1 stage in the cells that were exposed to 1% O2
for 48 hours in comparison with the cells cultivated at 20% O2 as
controls (P,0.05) (Figure 4D and E), indicating more cells in a
quiescent status under hypoxia.
Hypoxia increases the fraction of cells with stem-like
phenotype
Side population cells, assumed to contain putative prostate
cancer stem cells, are known to pump out the dye Hoechst 33342
[20,33]. Cells exhibiting this activity were further assessed during
cultivation at different oxygen tensions. Higher fractions of these
side population cells were observed in cultures kept at 1% O2
tension for 48 hours in comparison to the cells cultivated at 20%
O2 (Figure 5A and B).
ABCG2 and CD44 have been described as prostate cancer
stem-like markers based on clinical investigations and studies in
prostate cancer cell lines [19,33]. Therefore, ABCG2 and CD44
expressions in the PC-3 and DU145 cells that were incubated at
1% or 20% O2 tensions for 48 hours were examined with flow
cytometry. As shown in Figures 5C and D, threw were 1.20-fold
and 1.42-fold increase in ABCG2 expression in the PC-3 and
DU145 cells under 1% O2, respectively, in comparison to the cells
always cultivated under normoxia. Similarly, there were 1.50-fold
and 1.45-fold increases in CD44 expression in the PC-3 and
DU145 cells under 1% O2, respectively, in comparison to the cells
always cultivated under normoxia (Figures 5E and F).
Since hypoxia could induce both ABCG2 and CD44 expression
in both cell lines, we further investigated the relationship between
CD44 and ABCG2. Double staining of these two surface markers
revealed that the hypoxia-induced ABCG2
+ cells were primarily
CD44
bright cells, and the CD44
dim cells under the same culture
condition were mostly negative for ABCG2 expression (Figure 6A).
CD44
bright cells show stem-like properties
The sorted CD44
bright and CD44
dim cells were further
examined by immunoblotting. As shown in Figure 6B, in both
PC-3 and DU145 cell lines grown under normoxia, the CD44
bright
cells expressed higher levels of ABCG2, Oct3/4, and Nanog than
the CD44
dim cells. Hypoxic pretreatment of these cell lines for
48 hours resulted in even greater levels of expression of these
factors in the CD44
bright cells.
After verifying the higher stemness factor and ABCG2
expressions in the CD44
bright cells, both under hypoxia and
normoxia, we examined whether the CD44
bright cells had greater
colony formation capability (a property of stem-like cells). As can
be seen in Figures 7A and 7B, the CD44
bright cells formed
significantly more colonies compared to the CD44
dim cells. Next,
we tested how the CD44
bright and CD44
dim cells responded to
hypoxic pretreatment (1% O2), in comparison to the cells
consistently cultivated at normoxia. The CD44
bright cells which
were hypoxic-pretreated for 48 hours could form significantly
more colonies than the CD44
bright cells without hypoxic
pretreatment.
The sorted subpopulations of CD44
bright and CD44
dim cells
were additionally examined by sphere growth assays since sphere
growth is common in stem-like cells. As shown in Figure 7C, the
CD44
dim cells hardly formed any sphere, no matter the cells were
hypoxia pre-treated or not. However, there was a great number of
spheres in the CD44
bright cells from both cell lines, either from the
nomoxia or from the hypoxia pretreatment. Although there was
no significant sphere formation efficiency difference in the hypoxia
pre-treated CD44
bright cells compared to the nomoxia pre-treated
CD44
bright cells in both cell lines, the hypoxia pre-treated
CD44
bright cells in the PC-3 cell line demonstrated a 1.21-fold
increase in sphere formation efficiency, and the hypoxia pre-
treated CD44
bright cells in the DU145 cells revealed a 1.14-fold
increase in sphere formation efficiency, in comparison with their
control cells.
Discussion
Hypoxia often occurs in the inner part of solid tumors, creating
an environment where undifferentiated tumor cells can exist. For
prostate cancer, hypoxia is commonly associated with poor
prognosis [34]. In this study, we have demonstrated that hypoxia
can upregulate stem-like properties of the prostate cancer cell lines
PC-3 and DU145. It has been hypothesized that cancer stem-like
cells may persist as a distinct population within tumors and cause
relapse and metastasis following general cancer therapies like
radiotherapy and chemotherapy. Therefore, it is of great value to
identify factors that affect the stem-like properties of cancer cells
and to determine what conditions influence the differentiation of
stem cells.
The hypoxia inducible factors HIF-1a and HIF-2a are
reportedly activated in aggressive tumor cells [35,36]. HIF-1a
expression is increased in primary prostate cancers, prostate
cancer bone marrow metastasis of PC-3 and brain metastasis of
DU145, compared to in normal prostate epithelium [37,38]. In
this study, HIF-1a was weakly expressed under normoxia and
their expressions were increased under hypoxic conditions. This is
in agreement with earlier reports of higher expressions in response
to hypoxia [39–41]. In our study, HIF-2a was also upregulated in
response to hypoxia treatment in consistent with increased
expression of HIF-1a. Moreover, in a clinical observation, HIF-
1a expression was elevated in high-grade prostatic intraepithelial
neoplastic lesions (the precursor of a majority of invasive prostate
adenocarcinoma), relative to expression levels in normal epithe-
lium, stromal cells, and benign prostatic hyperplasia [42].
The biological impact of hypoxia is exerted through transcrip-
tional factors, such as Oct3/4 and Nanog [43]. Oct3/4 and Nanog
are key players in a transcriptional network for maintenance of
Figure 4. Hypoxic effects on cell proliferation, colony formation and cell cycle. (A) Cell proliferation curves show no statistical difference for
cell growth under different oxygen tensions (P.0.05). (B) Colony formation assay for both cell lines shows more colonies in the cells pre-treated at 7%
O2 for 48 hours and even more colonies in the cells pre-treated under 1% O2 (C) Histograms for the colony formation efficiency shows statistically
higher efficiency in the cells pre-treated under hypoxia (7% or 1% O2) for both cell lines (P,0.0001). (D) Flow cytometry shows extended G0/G1 stage
for both cell lines which have been cultivated under 1% O2 for 48 hours, in comparison to the cells always kept under normoxia. (E) Statistical
analyses reveal significantly extended G0/G1 stage in the cells cultivated under hypoxia for both cell lines (P,0.05).
doi:10.1371/journal.pone.0029170.g004
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Our present study revealed that Oct3/4 and Nanog were expressed
in the prostate cancer cell lines PC-3 and DU145, albeit in a lower
level. Invasive tumor cells are shown with a stem-like genomic
signature expressing a number of stem cell genes, including Oct3/4
and Nanog and these cells are more tumorigenic compared to their
non-invasive counterpart [44]. In our present study, we found that
the expressions of these genes were upregulated upon hypoxia
exposure, at both the mRNA and protein levels, in parallel with the
increasing expressions of HIF-1a and HIF-2a. The upregulation of
Oct3/4 expression could be correlated with the enhanced HIF-2a
expression under hypoxia and this observation is consistent with
previous findings that HIF-2a binds to the promoter of Oct3/4 and
induces its expression and activity directly [45], supporting a
potential role for the interaction of HIF-2a and Oct3/4 in prostate
cancer cells response to hypoxia.
Figure 5. Stem-like phenotype analyses by flow cytometry. PC-3 and DU145 cells were cultivated in 1% O2 and 20% O2 coditions for 48 hours
to analyze stem-like phenotype through flow cytometry assay. (A) The representative images show that side population cells were induced in both
cell lines after hypoxic treatment. (B) Statistic analyses show significant difference in side population. (C) Flow cytometry analyses show higher levels
of ABCG2 expression intensity in both cell lines under hypoxia. (D) Histogram shows statistically significant difference in ABCG2 expression. (E) Flow
cytometry analyses show higher CD44 expression intensity in both cell lines under hypoxia. (F) Histogram shows statistically significant difference in
CD44 expression.
doi:10.1371/journal.pone.0029170.g005
Figure 6. CD44
bright cells are mainly positive for ABCG2, Oct3/4 and Nanog. (A) Double staining of CD44 and ABCG2 surface markers with
flow cytometry assay shows higher levels expressions of these factors in both cell lines under hypoxia for 48 hours. (B) The CD44
bright cells under
normoxia express higher levels of ABCG2, Oct3/4 and Nanog, but the CD44
dim cells under the same normoxia condition express very low levels of
these factors. The CD44
bright cells pretreated under 1% O2 for 48 hours show even higher levels of these factors compared to the CD44
bright cells
cultivated under normoxia.
doi:10.1371/journal.pone.0029170.g006
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mRNA expression was derived from NANOG1 and/or NANOGP8
genes in response to hypoxia, specific primers and probes were
used to detect the expressions of these two genes in PC-3 and
DU145 cell lines under different oxygen tensions by quantitative
RT-PCR. In line with previous reports, there was extremely low
level NANOG1 expression in these cells [16,29]. Although hypoxia
could upregulate the expression of this gene in both cell lines, the
expressions of the gene in these cells were still very low even in the
cells under hypoxia. However, the NANOGP8 was expressed in
higher levels in both cell lines under normoxia, and its expression
was greatly upregulated by hypoxia, with up to 6-fold and 10-fold
increase in the PC-3 and DU145 cell lines, respectively, indicating
that NANOGP8 expression was predominantly influenced by
hypoxia. Since Nanog protein expression was upregulated under
hypoxia, and the cells under hypoxia revealed greater stem-like
features, our results may support the notion that NANOGP8 plays
an important role on the cancer stem-like properties in prostate
cancer cells [16,29].
It is well documented that oxygen plays an important role in the
development of tissues and cells. Hypoxia often occurs in
pathophysiological conditions, especially when growth exceeds
the blood supply in the tumor. It has been speculated that the
formation of a hypoxic niche may drive selection of cancer stem
cells that can maintain tumors by regulating specific developmen-
tal programs. Based on these reports, we wanted to know whether
hypoxia influenced cell proliferation. Although there was no
statistically significant difference between cells’ proliferation under
hypoxia compared to that under normoxia, the cells grew slowly
under hypoxia with extended G0/G1, indicating higher quiescent
status of these cells in hypoxia.
To study the effect of hypoxia on stem-like cell phenotypes, we
assessed the fraction of side population cells. The side population
assay has been successfully used for identification of cancer stem-
like cells in studies of common urological malignancies, including
prostate, bladder, and renal cancers [47]. Our experiments
revealed a significantly higher number of side population cells in
both the PC-3 and DU145 cells that were treated with 48 hours in
1% O2, strongly indicating that stem-like properties of these
cancer cells could be greatly upregulate in vitro. Side population
cells contain active ATP-cassette family members (e.g., ABCG2)
that can pump Hoechst 33342 dye out of the cells and ABCG2 is
associated with multi-drug resistance. Importantly, ABCG2 is a
key molecular determinant for the side population cells and has
been reviewed as a universal stem cell marker [33]. Consistent
with the elevated fraction of side population cells, the expression of
ABCG2 was correspondingly increased in the cells treated at 1%
O2 tension, in comparison with the cells cultivated at 20% O2 for
both cell lines. Since CD44 is considered a putative surface marker
for cancer stem/progenitor cells in breast and prostate cancers
[19,22,48,49], we analyzed CD44 expressions in these cells as well.
Our study showed that CD44 expression was significantly induced
under hypoxia. The putative prostate cancer stem-like cell marker
CD44 has been associated with prostate cancer stem like feature
[46], and has been indicated to play an essential role in the
quiescence of hematopoietic stem cells in the osteoblastic niche
[50]. The extended G0/G1 stage and induced CD44 and ABCG2
expressions in our present study may suggest more slow-cycling
cancer stem-like cells under hypoxia, which is in line with the study
reported by Ishimoto et al [51].
Both CD44 and ABCG2 have been strongly indicated as stem
cell markers in previous studies [19,52,53]. In the present study,
we examined these two factors in the same cell populations, in
order to explore whether their responses to hypoxic treatments
were related. Using flow cytometry, we found that most of the PC-
3 and DU145 cells were CD44 positive, but only a small portion of
cells in these two cell lines were ABCG2 positive. The ABCG2
positive cells were mostly CD44
bright cells, and hypoxia induced
expressions of CD44 and ABCG2 in both cell lines, indicating that
ABCG2 expression may be associated with CD44
bright cells. Next,
we sorted the CD44
bright cells and verified that they were primarily
strongly positivity for ABCG2. On the contrary, all the CD44
dim
cells were almost ABCG2 negative. Furthermore, there were
higher levels ABCG2 expressions in the hypoxia pretreated
CD44
bright cells than the CD44
bright cells without hypoxia-
pretreatment in both cell lines. Collectively, our results suggest a
strong association between ABCG2
+ and CD44
bright cells.
In consistent with previous report that both NANOGP8 mRNA
and Nanog protein are enriched in the CD44
bright human prostate
cancer cells [16], we also found that higher protein expressions of
Oct3/4 and Nanog in the CD44
bright cells compared to the
corresponding CD44
dim cells. Moreover, we examined additional
stemness features of these cells using colony formation and sphere
growth assays. These experiments showed that the CD44
bright cells
formed more colonies than the CD44
dim cells. The sphere growth
assay also showed significantly higher sphere formation efficiency
for the CD44
bright cells, and this finding is supported by the former
report that CD44
bright prostate cancer cells display stem –like
characteristics such as more proliferative, clonogenic, tumorigenic
and metastatic than the corresponding CD44
dim cells [54].
Furthermore, the colony efficiency of the CD44
bright cells was
significantly improved following hypoxic pretreatment, whereas
the CD44
dim cells did not respond to such hypoxic exposure. Since
colony formation and sphere formation capabilities are confined to
stem cells [46,55,56], these results may support the hypothesis that
CD44
bright cells possess stem-like properties in the prostate cancer
cells [54].
In summary, hypoxia enhanced the stem-like properties of the
human prostate cancer cell lines PC-3 and DU145. Hypoxic
treatment also induced growth capability of CD44 positive cells in
these two cell lines, and CD44
bright cells possessed greater stem
cell-like features, as verified by higher expressions of stemness
factors and ABCG2, and significantly higher colony and sphere
formation efficiency. Furthermore, the stem-like properties of
the CD44
bright cells were significantly increased upon hypoxic
pretreatment.
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Figure 7. CD44
bright cells show stem-like properties. (A) For both PC-3 and DU145 cell lines, more colonies are shown in the CD44
bright cells
than the CD44
dim cells under nomoxia condition, while even more colonies can be seen in the CD44
bright cells pretreated under 1% O2 for 48 hours.
(B) Histograms for the colony formation efficiency show statistically significantly higher efficiency in the CD44
bright cells than the corresponding
CD44
dim cells (P,0.0001 for both cell lines), and even higher level efficiency in the hypoxia- pretreated CD44
bright cells in comparisons with the
CD44
bright cells without hypoxic pretreatment (P,0.05 for both cell lines). (C) Sphere formation assay shows spheres in the CD44
bright cells in both
normoxia and hypoxic pretreated cells while there is no qualified sphere in the corresponding CD44
dim cells for both cell lines. (D) Histograms show
sphere formation efficiency in the CD44
bright and CD44
dim cells with and without hypoxia pretreatment.
doi:10.1371/journal.pone.0029170.g007
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